SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-021484
Filing Date
2017-11-03
Accepted
2017-11-03 14:57:16
Documents
54
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q myok-10q_20170930.htm 10-Q 1626035
2 EX-31.1 myok-ex311_7.htm EX-31.1 15759
3 EX-31.2 myok-ex312_8.htm EX-31.2 15872
4 EX-32.1 myok-ex321_6.htm EX-32.1 8879
  Complete submission text file 0001564590-17-021484.txt   4979742

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT myok-20170930.xml EX-101.INS 997580
6 XBRL TAXONOMY EXTENSION SCHEMA myok-20170930.xsd EX-101.SCH 39043
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myok-20170930_cal.xml EX-101.CAL 34429
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE myok-20170930_def.xml EX-101.DEF 103221
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20170930_lab.xml EX-101.LAB 276728
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20170930_pre.xml EX-101.PRE 203215
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37609 | Film No.: 171176056
SIC: 2834 Pharmaceutical Preparations